Dennis C. Thompson

Vitreous: an inhibitor of retinal extract-induced neovascularization.

G. A. Lutty, Dennis C. Thompson, J Y Gallup et al. · PubMed · 1983 · 80 citations

Ocular Disease, Retinal Neovascularization, Immunology +17

Antagonism of Serotonin 5‐HT_1A Receptors Potentiates the Increases in Extracellular Monoamines Induced by Duloxetine in Rat Hypothalamus

Eric A. Engleman, David W. Robertson, Dennis C. Thompson et al. · Journal of Neurochemistry · 1996 · 36 citations

Extracellular Monoamines Induced, Serotonin 5-Ht1a Antagonist, Neurotransmitter +20

Synthesis and Structure−Activity Relationships of Potent and Orally Active 5-HT₄ Receptor Antagonists:  Indazole and Benzimidazolone Derivatives

John M. Schaus, Dennis C. Thompson, William E. Bloomquist et al. · Journal of Medicinal Chemistry · 1998 · 34 citations · Full text

Benzimidazolone Derivatives, Medicinal Chemistry, Antagonist Affinity +12

Expedient synthesis and biochemical properties of an [125I]-labeled analogue of glyburide, a radioligand for ATP-inhibited potassium channels

David W. Robertson, Douglas A. Schober, Joseph H. Krushinski et al. · Journal of Medicinal Chemistry · 1990 · 19 citations

Glycobiology, Altmetric Attention Score, Atp-inhibited Potassium Channels +18

LY353433, a potent, orally effective, long-acting 5-HT(4) receptor antagonist: comparison to cisapride and RS23597-190.

Marlene L. Cohen, William Bloomquist, John M. Schaus et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 16 citations